NASDAQ: FENC - Fennec Pharmaceuticals Inc.

Lønnsomhet i seks måneder: +25.13%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Fennec Pharmaceuticals Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2001-06-05
ISIN CA31447P1009
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.fennecpharma.com
Цена ао 6.75
Prisendring per dag: +2.18% (6.87)
Prisendring per uke: +5.56% (6.65)
Prisendring per måned: +8.5% (6.47)
Prisendring over 3 måneder: +15.84% (6.06)
Prisendring over seks måneder: +25.13% (5.61)
Prisendring per år: -28.51% (9.82)
Prisendring over 3 år: +37.92% (5.09)
Prisendring over 5 år: +5.41% (6.66)
Prisendring over 10 år: 0% (7.02)
Prisendring siden begynnelsen av året: +13.96% (6.16)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 13.46 1
P/BV -25.19 0
P/E 0 0
EV/EBITDA -23.65 0
Total: 2.88

Effektivitet

Navn Betydning Karakter
ROA, % -61.13 0
ROE, % 141.31 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -2.38 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 3219999900 10
Lønnsomhet Ebitda, % -4.89 0
Lønnsomhet EPS, % -3.27 0
Total: 4.6
Flere detaljer

Institusjoner Volum Dele, %
Southpoint Capital Advisors LP 4077214 15.04
Sonic Gp LLC 2407357 8.88
Solas Capital Management, LLC 1378513 5.09
Avoro Capital Advisors LLC 1200000 4.43
Vanguard Group Inc 1140063 4.21
DG Capital Management, LLC 1075634 3.97
Blackrock Inc. 934591 3.45
Harbert Fund Advisors, Inc. 466869 1.72
AIGH Capital Management LLC 329370 1.22
Gendell, Jeffrey L. 282478 1.04



Veileder Stillingstittel Betaling Fødselsår
Mr. Rostislav Raykov CEO & Director 885.07k 1976 (49 år)
Mr. Robert C. Andrade Chief Financial Officer 600.88k 1975 (50 år)
Mr. Lei Fang President of Pharstat Inc N/A
Mr. Mark Gowland Controller

Adresse: United States, Research Triangle Park. NC, 68 TW Alexander Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.fennecpharma.com